DexCom, Inc. vs Li Auto Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Li Auto Inc trades at $12.62 (market cap $12.28B). The key difference: DexCom, Inc. is far larger — about 2.8× Li Auto Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Li Auto Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | LI | |
|---|---|---|
Market Cap | $33.79B | $12.28B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $26.69 |
52-Week Low | $54.84 | $11.74 |
Enterprise Value | $33.24B | $1.11B |
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 90,000 EVs in 2021, accounting for about 2.7% of China's passenger new energy vehicle market. Beyond Li One, the company will expand its product line, including both BEVs and PHEVs, to target a broader consumer base.
Read more on LI →